![akila srinivasan akila srinivasan](http://www.carnaticchamberconcerts.com/wp-content/uploads/2018/10/AlaapR.jpg)
Why did it take you so long when you have so many offices and so many agents working for you? You are a late entrant in the insurance market. Now, they will sell our life insurance policies also. In 32 years, our (Shriram's) chit funds companies have built a huge network of around 600 offices in the country with 65,000 agents. To develop at least 100,000 of agents, it will take 15-20 years. That is because insurance companies cannot achieve market penetration overnight they have to develop an agency force which is a 10-year process. I expect it to go up to 5% though it is a tall order. I think competition from private sector will see the market share going up. I feel we have hardly tapped the Indian market after all, we have a population of 1 billion people. In a developing economy like South Africa, it is 16% of the GDP. Life insurance penetration in countries like India and China is very low while in the developed areas like Europe and the United States, it is around 7%. Now that more and more private players are entering the field, how much more do you expect it to grow in the next 5-10 years? The insurance sector in India accounts for only 2% of India's GDP. In this interview with, she talks not only about the insurance sector in India but also about the Indian economy, the stock market, and also the proposed reservation in private sector. Last month, the Royal Netherlands Embassy and Consulates General appointed Akhila Srinivasan as Honorary Consul of the Kingdom of the Netherlands.
![akila srinivasan akila srinivasan](https://www.mawratanews.lk/wp-content/uploads/2019/08/Akila-1.jpg)
In 2005, she took over as the managing director of the newly floated Shriram Life Insurance. She joined the Shriram Group in 1986 as a management trainee, and in 2000, she was made the managing director of Shriram Investments. There are very few women executives in the financial services sector, and she is one among the few. She is also one of the key board-level executives of the Shriram Group, and the only female MD in the group. The Journal of Steroid Biochemistry and Molecular Biology.2021 212(0)105922ĭrug Metabolism and Personalized Therapy.Akhila Srinivasan is the managing director of Shriram Life Insurance Company Ltd, which is part of the Rs 6,000 crore (Rs 60 billion) Shriram Group. Hanna,Cristiano Rizzo,Radwa Marawan Abdel Halim,Hemmat Elewa El Haddad,Randa Salam,Hazem El-Sayed Abou-Youssef Vitamin D status in Hashimoto’s thyroiditis and its association with vitamin D receptor genetic variants Sandhiya Selvarajan,Akila Srinivasan,Deepanjali Surendran,Jayanthi Mathaiyan,Sadishkumar Kamalanathanĭrug Metabolism and Personalized Therapy.2021 0(0)1375 Journal of Diabetes & Metabolic Disorders.2021 20(2)1375Īssociation of genetic polymorphisms in vitamin D receptor (ApaI, TaqI and FokI) with vitamin D and glycemic status in type 2 diabetes patients from Southern India Maryam Ghodsi,Abbas Ali Keshtkar,Farideh Razi,Mahsa Mohammad Amoli,Ensieh Nasli-Esfahani,Fariba Zarrabi,Patricia Khashayar,Alireza Khajavi,Bagher Larijani,Mohamad Reza Mohajeri-Tehrani Journal of Diabetes & Metabolic Disorders.2021 20(1)845Īssociation of vitamin D receptor gene polymorphism with the occurrence of low bone density, osteopenia, and osteoporosis in patients with type 2 diabetes Surendar Aravindhan,Mohammed Fadhil Mohammed Almasoody,Nihad Abdallah Selman,Alekhina Natalia Andreevna,Sahithya Ravali,Payam Mohammadi,Mohammad Masoud Eslami,Bahman Razi,Saeed Aslani,Danyal Imani
![akila srinivasan akila srinivasan](http://www.carnaticchamberconcerts.com/wp-content/uploads/2019/11/AnaghaBalaji.png)
Vitamin D Receptor gene polymorphisms and susceptibility to type 2 diabetes: evidence from a meta-regression and meta-analysis based on 47 studies